Thomas Franke - Omega Healthcare Independent Director
| OHI Stock | USD 30.68 0.01 0.03% |
Director
Mr. Thomas F. Franke is Independent Director of Omega Healthcare Investors Inc. Mr. Franke is Chairman and a principal owner of Cambridge Partners Inc. an owner developer and manager of multifamily housing in Grand Rapids Michigan. He is also a founder in 1992 of Laurel Health Care Inc. and serves as the Chairman Emeritus of Laurel. At one time he was a principal owner of Abacus Hotels LTD. . Mr. Franke was a founder and previously a director of Principal Healthcare Finance Limited and Omega Worldwide Inc. since 1992.
| Age | 84 |
| Tenure | 32 years |
| Address | 303 International Circle, Hunt Valley, MD, United States, 21030-1394 |
| Phone | 410 427 1700 |
| Web | https://www.omegahealthcare.com |
Omega Healthcare Management Efficiency
The company has Return on Asset of 0.033 % which means that on every $100 spent on assets, it made $0.033 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0658 %, implying that it generated $0.0658 on every 100 dollars invested. Omega Healthcare's management efficiency ratios could be used to measure how well Omega Healthcare manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to 0.03. The current Return On Capital Employed is estimated to decrease to 0.08. As of now, Omega Healthcare's Other Assets are increasing as compared to previous years. The Omega Healthcare's current Total Current Assets is estimated to increase to about 2.4 B, while Intangible Assets are projected to decrease to under 647.9 K.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Richard Gilchrist | Ventas Inc | 74 | |
| Robert Ettl | Sabra Healthcare REIT | 58 | |
| James Shelton | Ventas Inc | 66 | |
| James Morey | Universal Health Realty | 52 | |
| Roxanne Martino | Ventas Inc | 63 | |
| Jing Zhang | Global Medical REIT | 52 | |
| Errol Biggs | Healthcare Realty Trust | 73 | |
| Yanping Huang | Global Medical REIT | 53 | |
| Conn Flanigan | Global Medical REIT | 48 | |
| Craig Barbarosh | Sabra Healthcare REIT | 50 | |
| Ronald Geary | Sabra Healthcare REIT | 70 | |
| Douglas Crocker | Ventas Inc | 74 | |
| John Abbott | Healthcare Realty Trust | 66 | |
| Boyd Hendrickson | LTC Properties | 75 | |
| Roger West | Healthcare Realty Trust | 69 | |
| Robert McCabe | National Health Investors | 70 | |
| Ronald Marston | Global Medical REIT | 78 | |
| Jeffrey Malehorn | Sabra Healthcare REIT | 57 | |
| Huiqi Zhang | Global Medical REIT | 31 | |
| Jon Kline | CareTrust REIT | 51 | |
| Paula Crowley | Global Medical REIT | 66 | |
Management Performance
| Return On Equity | 0.0658 | ||||
| Return On Asset | 0.033 |
Omega Healthcare Inv Leadership Team
Elected by the shareholders, the Omega Healthcare's board of directors comprises two types of representatives: Omega Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Omega. The board's role is to monitor Omega Healthcare's management team and ensure that shareholders' interests are well served. Omega Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Omega Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Norman Bobins, Independent Director | ||
| Craig Bernfield, Director | ||
| Taylor CPA, CEO Director | ||
| Matthew Gourmand, IR Contact Officer | ||
| Thomas Peterson, IR Contact Officer | ||
| Burke Whitman, Independent Director | ||
| Craig Callen, Independent Chairman of the Board | ||
| Samuel Kovitz, Senior VP | ||
| Daniel Booth, Chief Operating Officer | ||
| Michael Ritz, Chief Accounting Officer | ||
| Barbara Hill, Independent Director | ||
| Vikas Gupta, Senior Development | ||
| Harold Kloosterman, Independent Director | ||
| Ben Perks, Director | ||
| Kapila Anand, Independent Director | ||
| Neal Ballew, Senior Vice President Chief Accounting Officer | ||
| Edward Lowenthal, Independent Director | ||
| Benjamin Perks, Independent Director | ||
| Bernard Korman, Independent Chairman of the Board | ||
| Thomas Franke, Independent Director | ||
| C Pickett, Chief Executive Officer, Director | ||
| Kevin Jacobs, Independent Director | ||
| Megan Krull, Senior Operations | ||
| Michele Reber, Director Management | ||
| Robert Stephenson, Chief Financial Officer | ||
| Steven Insoft, Chief Corporate Development Officer | ||
| Gail Makode, Chief Legal Officer, General Counsel | ||
| Stephen Plavin, Independent Director | ||
| Taylor Pickett, CEO, Director | ||
| Lisa EgbuonuDavis, Director |
Omega Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Omega Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0658 | ||||
| Return On Asset | 0.033 | ||||
| Profit Margin | 0.26 % | ||||
| Operating Margin | 0.46 % | ||||
| Current Valuation | 12.38 B | ||||
| Shares Outstanding | 245.3 M | ||||
| Shares Owned By Insiders | 0.29 % | ||||
| Shares Owned By Institutions | 67.06 % | ||||
| Number Of Shares Shorted | 13.42 M | ||||
| Price To Earning | 30.17 X |
Omega Healthcare Investors Sentiment
The influence of Omega Healthcare's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Omega. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Omega Healthcare's public news can be used to forecast risks associated with an investment in Omega. The trend in average sentiment can be used to explain how an investor holding Omega can time the market purely based on public headlines and social activities around Omega Healthcare Investors. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Omega Healthcare's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Omega Healthcare's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Omega Healthcare's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Omega Healthcare.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Omega Healthcare in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Omega Healthcare's short interest history, or implied volatility extrapolated from Omega Healthcare options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omega Healthcare Investors. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Omega Healthcare Inv information on this page should be used as a complementary analysis to other Omega Healthcare's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for Omega Stock analysis
When running Omega Healthcare's price analysis, check to measure Omega Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Omega Healthcare is operating at the current time. Most of Omega Healthcare's value examination focuses on studying past and present price action to predict the probability of Omega Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Omega Healthcare's price. Additionally, you may evaluate how the addition of Omega Healthcare to your portfolios can decrease your overall portfolio volatility.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |
Is Omega Healthcare's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omega Healthcare. If investors know Omega will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omega Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.148 | Dividend Share 2.68 | Earnings Share 1 | Revenue Per Share 3.949 | Quarterly Revenue Growth 0.652 |
The market value of Omega Healthcare Inv is measured differently than its book value, which is the value of Omega that is recorded on the company's balance sheet. Investors also form their own opinion of Omega Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Omega Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omega Healthcare's market value can be influenced by many factors that don't directly affect Omega Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Omega Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Omega Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omega Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.